Firy Inc. vs Zoetis Inc — how do they compare? Firy Inc. trades at $10.21 (market cap $159.51M), while Zoetis Inc trades at $74.9 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 195.2× Firy Inc.'s market cap, and Zoetis Inc pays a 2.81% dividend while Firy Inc. pays none. Which is the better fit depends on your goals.
| FIRY | ZTS | |
|---|---|---|
Market Cap | $159.51M | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.45 | $156.76 |
52-Week Low | $2.28 | $71.91 |
Enterprise Value | $103.18M | $38.70B |
Dividend Yield | — | 2.81% |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $10.48, up 0.29% today, with a bullish technical outlook from moving averages. The company shows improving revenue trends ($104.5M in 2025) but continues to report significant losses (-$70.41M net income). Recent developments include a $719 million legal victory and corporate rebranding from Skillz Inc. Analyst sentiment remains mixed with a 60% hold rating.
The stock presents speculative potential from legal wins and revenue stabilization, but persistent negative margins and cash burn (-$86.41M net cash flow) pose substantial risks. Upside depends on achieving profitability, while downside risk remains elevated from ongoing operational losses.
No Aura AI signal available yet.
Trailing returns across standard periods
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →